Impulsator, Product Number: S00010, Phasitron 5, Product Number: P5 used with Instruction Manual
FDA Device Recall #Z-3323-2026 - Class II, August 18, 2026
Recall Summary
| Recall Number | Z-3323-2026 |
| Classification | Class II - Moderate risk |
| Date Initiated | August 18, 2026 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Percussionaire Corporation |
| Location | Sandpoint, ID |
| Product Type | Devices |
| Quantity | 228,277 |
Product Description
Impulsator, Product Number: S00010, Phasitron 5, Product Number: P5 used with Instruction Manual
Reason for Recall
Labeling updated warning not to use Intrapulmonary percussive ventilation (IPV) in conjunction with volatile anesthetic delivery systems because IPV may alter controlled delivery of volatile anesthetic agents, resulting in deeper/lighter anesthetic effects that may result in hypertonia/hypotonia, tachycardia/ bradycardia, elevated intracranial pressure, awareness during anesthesia, oversedation
Distribution Pattern
Worldwide - US Nationwide distribution including in the states of CA, PA, OK, GA, TX, OH, WI, WA, NY, MO, FL, DE, LA, SC, WV, NJ, NE, KS, NC, AL, CO, VA, OR, AZ, IL, CT, ID, NH, UT, TN, MD, VT, MS, NV, DC, ME, IA, AR, HI, ND, IN, MT, NM, MN, MI, SD, MA, AK, RI and the countries of Canada, Belgium, Chile, France, Germany, Israel, Italy, Latvia, Netherlands, Norway, Oman, Philippines, Portugal, Qatar, Russia, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, Kuwait, Australia, South Africa.
Lot / Code Information
Product Number/UDI-DI: S00010/00849436000389, P5/00849436000501, Instruction Manual: P20047 Rev E
Other Recalls from Percussionaire Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-3324-2026 | Class II | Travel Air, Product Number: S00055; Phasitron 5... | Aug 18, 2026 |
| Z-3320-2026 | Class II | In-Line Valve, Product Number: P5-TEE | Aug 18, 2026 |
| Z-3325-2026 | Class II | Intrapulmonary Percussive Ventilation, IPV HC, ... | Aug 18, 2026 |
| Z-3319-2026 | Class II | Intrapulmonary Percussive Ventilation, IPV 1, P... | Aug 18, 2026 |
| Z-3322-2026 | Class II | Intrapulmonary Percussive Ventilation, IPV-2C, ... | Aug 18, 2026 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.